111437-76-4

Upstream product

• 111437-63-9 pentafluorophenyl 2(S)-methyl-9(S)-<(benzyloxycarbonyl)amino>-3-(tert-butyloxycarbonyl)-3-aza-7,11,13-trioxatetradecanoate 
• 111437-62-8 methyl 2(S)-methyl-9(S)-<(benzyloxycarbonyl)amino>-3-(tert-butyloxycarbonyl)-3-aza-7,11,13-trioxatetradecanoate 
• 111437-65-1 <3R-<3R*,6S*,7(S*)>>-<2--2-oxo-1-(phenylmethyl)ethyl>carbamic acid 1,1-dimethylethyl ester 
• 111437-66-2 <3S-<3R*,6R*,7(R*)>>-<2-(hexahydro-3-formyl-6-methyl-5-oxo-2H-1,4,7-oxadiazecin-7(8H)-yl)-2-oxo-1-(phenylmethyl)ethyl>carbamic acid 1,1-dimethylethyl ester 
• 111437-61-7 methyl 2(S)-methyl-9(S)-<(benzyloxycarbonyl)amino>-3-aza-7,11,13-trioxatetradecanoate 
• 111437-64-0 <3S-(3R*,6R*)>-hexahydro-3-<(methoxymethoxy)methyl>-6-methyl-5-oxo-2H-1,4,7-oxadiazecine-7(8H)-carboxylic acid 1,1-dimethylethyl ester 
• 111437-59-3 6(S)-<(benzyloxycarbonyl)amino>-4,8,10-trioxaundecan-1-ol 
• 111437-60-6 6(S)-<(benzyloxycarbonyl)amino>-4,8,10-trioxaundecanal 
• 111437-58-2 6(S)-<(benzyloxycarbonyl)amino>-4,8,10-trioxaundec-1-ene 
• 111437-56-0 N-(benzyloxycarbonyl)-O-allyl-L-serine methyl ester 
• 111437-57-1 N-(benzyloxycarbonyl)-O-allyl-L-serinol 
• 111437-67-3 <3R-<3R*,6S*,7(S*)>>-N-<<7-<2-<<(1,1-dimethylethoxy)carbonyl>amino>-1-oxo-3-phenylpropyl>octahydro-6-methyl-5-oxo-2H-1,4,7-oxadiazecin-3-yl>methyl>-L-valine phenylmethyl ester 

Downstream Products

• 106975-94-4 <3R-<3R*,6S*,7(S*)>>-N-amino>-1-oxo-3-phenylpropyl>octahydro-6-methyl-5-oxo-2H-1,4,7-oxadiazecin-3-yl>methyl>-L-valyl>-L-isoleucyl>-L-histidine methyl ester 

Relevant academic research and scientific papers

Renin Inhibitors. Design and Synthesis of a New Class of Conformationally Restricted Analogues of Angiotensinogen

Molecular modeling methods have been used to design a novel series of conformationally constrained cyclic peptide inhibitors of human renin.Three goals were defined: enhanced inhibitory potency, high specificity for renin, and increased metabolic stabilit